Back to Search
Start Over
Mucormycosis in COVID-19
- Source :
- APIK Journal of Internal Medicine, Vol 9, Iss 4, Pp 209-214 (2021)
- Publication Year :
- 2021
- Publisher :
- Wolters Kluwer Medknow Publications, 2021.
-
Abstract
- Mucormycosis has emerged as a disease of immense importance, especially owing to the surge of cases during the second wave of COVID pandemic. Various factors are being attributed to the sudden burst of cases in our country, such as higher fungal spore counts in tropical climate, uncontrolled diabetes mellitus, prolonged steroid therapy, contamination of oxygen facilities, respiratory equipment, reused face mask, and zinc supplements. The need of the hour is to emphasize on awareness of early warning signs, as the benefits appear to be time sensitive.
- Subjects :
- covid-19
diabetes
mucormycosis
steroids
Internal medicine
RC31-1245
Subjects
Details
- Language :
- English
- ISSN :
- 26661802 and 26661810
- Volume :
- 9
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- APIK Journal of Internal Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.2029bff073dc455f94934112698fe3d4
- Document Type :
- article
- Full Text :
- https://doi.org/10.4103/ajim.ajim_74_21